Replimune Group Inc.(REPL)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

REPL Replimune Group Inc.

休市中 04-19 16:00:00 EDT

6.45

-0.52

-7.46%

盘后6.45

+0.000.00%

19:57 EDT

最高7.07	最低6.33	成交量86.68万
今开6.90	昨收6.97	日振幅10.62%
总市值3.96亿	流通市值2.52亿	总股本6,139万
成交额566.68万	换手率2.22%	流通股本3,905万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"REPL","market":"US","secType":"STK","nameCN":"Replimune Group Inc.","latestPrice":6.45,"timestamp":1713556800000,"preClose":6.97,"halted":0,"volume":866786,"hourTrading":{"tag":"盘后","latestPrice":6.45,"preClose":6.45,"latestTime":"19:57 EDT","volume":18875,"amount":121753.684,"timestamp":1713571073561},"delay":0,"floatShares":39049900,"shares":61387786,"eps":-3.162073,"marketStatus":"休市中","marketStatusCode":7,"change":-0.52,"latestTime":"04-19 16:00:00 EDT","open":6.9,"high":7.07,"low":6.33,"amount":5666767.9362652,"amplitude":0.106169,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.162073,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1713772800000},"adr":0,"listingDate":1532059200000,"adjPreClose":6.97,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":6.45,"preClose":6.45,"latestTime":"19:57 EDT","volume":18875,"amount":121753.684,"timestamp":1713571073561},"volumeRatio":0.9550518963041854},"requestUrl":"/m/hq/s/REPL","defaultTab":"news","newsList":[{"id":"2428663639","title":"Replimune Group, Inc.盘中异动 急速下跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428663639","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428663639?lang=zh_cn&edition=full","pubTime":"2024-04-19 23:00","pubTimestamp":1713538811,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日23时00分，Replimune Group, Inc.股票出现波动，股价大幅跳水5.24%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Chromocell Therapeutics Corporation、Kintara Therapeutics, Inc.涨幅较大，Bio-Path Holdings, Inc.、Kintara Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为196.31%、10.76%、8.10%，振幅较大的相关个股有Chromocell Therapeutics Corporation、Portage Biotech Inc.、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为34.28%、27.12%、23.85%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192300127a542259&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192300127a542259&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426630293","title":"Replimune Group, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426630293","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426630293?lang=zh_cn&edition=full","pubTime":"2024-04-12 01:20","pubTimestamp":1712856039,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日01时20分，Replimune Group, Inc.股票出现异动，股价快速上涨5.03%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Rallybio Corporation、Eliem Therapeutics, Inc、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Adial Pharmaceuticals, Inc、Aptevo Therapeutics Inc.、Scisparc Ltd.较为活跃，换手率分别为764.26%、568.26%、509.21%，振幅较大的相关个股有Rallybio Corporation、Tc Biopharm  Plc C/Wts 10/02/2028 、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为50.92%、46.31%、42.60%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412012040791ff5cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412012040791ff5cf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426494091","title":"Replimune Group, Inc.盘中异动 早盘大幅下挫5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426494091","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426494091?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:30","pubTimestamp":1712755859,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时30分，Replimune Group, Inc.股票出现异动，股价急速下挫5.91%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Adial Pharmaceuticals, Inc、Jaguar Health, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为823.94%、61.97%、20.62%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、X4制药、Foghorn Therapeutics Inc.，振幅分别为19.47%、13.39%、9.52%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213059861e4a35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213059861e4a35&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425591870","title":"Replimune Group, Inc.盘中异动 快速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425591870","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425591870?lang=zh_cn&edition=full","pubTime":"2024-04-06 01:20","pubTimestamp":1712337638,"startTime":"0","endTime":"0","summary":"北京时间2024年04月06日01时20分，Replimune Group, Inc.股票出现异动，股价快速上涨5.04%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为1.27%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Moolec Science Sa C/Wts 、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Candel Therapeutics, Inc.、Protara Therapeutics, Inc.、Effector Therapeutics, Inc.较为活跃，换手率分别为229.02%、69.92%、51.94%，振幅较大的相关个股有Candel Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为90.94%、58.90%、45.85%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040601203887e7e317&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040601203887e7e317&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424039757","title":"Replimune Group, Inc.盘中异动 早盘快速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424039757","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424039757?lang=zh_cn&edition=full","pubTime":"2024-04-04 21:51","pubTimestamp":1712238713,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日21时51分，Replimune Group, Inc.股票出现异动，股价急速上涨5.10%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Tc Biopharm  Plc、Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc.涨幅较大，Tc Biopharm  Plc、Candel Therapeutics, Inc.、Eiger Biopharmaceuticals, Inc.较为活跃，换手率分别为1917.88%、33.43%、22.94%，振幅较大的相关个股有Tc Biopharm  Plc、Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为90.00%、70.00%、42.86%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404215154861e368f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404215154861e368f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422961269","title":"Replimune Group, Inc.盘中异动 早盘股价大跌5.09%报7.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422961269","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422961269?lang=zh_cn&edition=full","pubTime":"2024-03-26 22:31","pubTimestamp":1711463485,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日22时31分，Replimune Group, Inc.股票出现异动，股价急速下跌5.09%。截至发稿，该股报7.64美元/股，成交量8.1655万股，换手率0.13%，振幅7.20%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Nutriband Inc C/Wts 、Artelo Biosciences Inc C/Wts 20/06/2024 、Stoke Therapeutics, Inc.涨幅较大，Abvc Biopharma, Inc.、Altamira Therapeutics Ltd.、Stoke Therapeutics, Inc.较为活跃，换手率分别为204.87%、28.36%、27.83%，振幅较大的相关个股有Nutriband Inc C/Wts 、Stoke Therapeutics, Inc.、Mesoblast Ltd，振幅分别为109.68%、34.92%、32.27%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032622312587e7bdfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032622312587e7bdfa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421321046","title":"Replimune Group, Inc.盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421321046","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421321046?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:44","pubTimestamp":1711028687,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时44分，Replimune Group, Inc.股票出现异动，股价快速上涨5.12%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Portage Biotech Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Scisparc Ltd.、Bionomics Ltd Ads Each Rep 180 Ord Shs、Xtl生物制药较为活跃，换手率分别为71.75%、15.00%、14.86%，振幅较大的相关个股有Portage Biotech Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Briacell Therapeutics Corp C/Wts，振幅分别为44.42%、22.90%、19.40%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212144477a4e4131&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212144477a4e4131&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.replimune.com","stockEarnings":[{"period":"1week","weight":-0.0966},{"period":"1month","weight":-0.2047},{"period":"3month","weight":-0.1423},{"period":"6month","weight":-0.5654},{"period":"1year","weight":-0.6124},{"period":"ytd","weight":-0.2349}],"compareEarnings":[{"period":"1week","weight":-0.0307},{"period":"1month","weight":-0.0486},{"period":"3month","weight":0.0264},{"period":"6month","weight":0.1756},{"period":"1year","weight":0.2022},{"period":"ytd","weight":0.0418}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Replimune Group, Inc.于2015年在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，致力于应用他们在溶瘤免疫治疗领域的领先专业技术，改变癌症患者的生活。使用该公司专有的Immulytic平台来设计和开发旨在最大限度激活免疫系统对抗癌症的候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.002034},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.066883},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.078936},{"month":4,"riseRate":0.5,"avgChangeRate":0.140001},{"month":5,"riseRate":0.6,"avgChangeRate":-0.017819},{"month":6,"riseRate":0.8,"avgChangeRate":0.16384},{"month":7,"riseRate":0.2,"avgChangeRate":-0.097379},{"month":8,"riseRate":0.333333,"avgChangeRate":0.067123},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.049404},{"month":10,"riseRate":0.5,"avgChangeRate":0.124924},{"month":11,"riseRate":0.5,"avgChangeRate":0.010871},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.088051}],"exchange":"NASDAQ","name":"Replimune Group Inc.","nameEN":"Replimune Group Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Replimune Group Inc.(REPL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Replimune Group Inc.(REPL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Replimune Group Inc.,REPL,Replimune Group Inc.股票,Replimune Group Inc.股票老虎,Replimune Group Inc.股票老虎国际,Replimune Group Inc.行情,Replimune Group Inc.股票行情,Replimune Group Inc.股价,Replimune Group Inc.股市,Replimune Group Inc.股票价格,Replimune Group Inc.股票交易,Replimune Group Inc.股票购买,Replimune Group Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Replimune Group Inc.(REPL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Replimune Group Inc.(REPL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况